Lyell Immunopharma Statistics
NASDAQ: LYELHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.80+0.22 (+1.62%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lyell Immunopharma by the numbers
Lyell Immunopharma has a market capitalization of $441.8 million based on 32.02M shares outstanding. With trailing EPS of $-12.61, Lyell Immunopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.6% above its 50-day average and 14.4% below its 200-day average.
Average daily trading volume is 174.76K shares, or about $2.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LYEL valuation vs. peer median
| Metric | LYEL | Peer median | Difference |
|---|---|---|---|
| Market cap | $441.82M | $438.09M | +1% |
| Avg. volume | 174.76K | 887.14K | -80% |
Peer median across 8 companies: AQST, INDP, EOLS, CAPR, CTMX, AMRN, DMAC, ARVN.
Valuation
- Market cap
- $441.82M
- Price / sales (latest FY)
- 12,272.69
- EPS (TTM)
- $-12.61
- Shares outstanding
- 32.02M
Price and trading
- Previous close
- 13.58
- Open
- 13.36
- Day range
- 13.30 – 14.30
- 52-week range
- 7.20 – 45.00
- 52-week change
- -27.86%
- Beta
- —
- Volume
- 171.09K
- Average volume
- 174.76K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 441.82M
- Forward Pe
- -2.34
- Eps
- -12.61
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 45.00
- Week52 Low
- 7.20
- Avg Volume
- 174.76K
- Shares Outstanding
- 32.02M
- Ma50
- 11.08
- Ma200
- 16.12
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -69.33%
- Pct From52w Low
- 91.80%